Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi. (Q42336329)
Jump to navigation
Jump to search
scientific article published on 12 January 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi. |
scientific article published on 12 January 2017 |
Statements
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi (English)
Manuela Ceccarelli
Caterina Stelitano
Angela Ferrari
Flavia Salvi
Annalisa Arcari
Gerardo Musuraca
Barbara Botto
Claudia Cellini
Caterina Patti
Anna M Liberati
Claudia Minotto
Stefano Volpetti
Antonella Ferranti
Elisa Montechiarello
James Carmichael
12 January 2017